▶ 調査レポート

神経障害性疼痛管理の世界市場

• 英文タイトル:Global Market Study of Neuropathic Pain Management: Rise in Number of Pain Management Centers and Availability of Approved Drugs Shaping the Future

Persistence Market Researchが調査・発行した産業分析レポートです。神経障害性疼痛管理の世界市場 / Global Market Study of Neuropathic Pain Management: Rise in Number of Pain Management Centers and Availability of Approved Drugs Shaping the Future / PMR-20JN003資料のイメージです。• レポートコード:PMR-20JN003
• 出版社/出版日:Persistence Market Research / 2020年1月20日
• レポート形態:英文、PDF、182ページ
• 納品方法:Eメール
• 産業分類:ライフサイエンス&革新医療
• 販売価格(消費税別)
  Individual User(1名用)¥543,900 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥843,600 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,176,600 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、神経障害性疼痛管理の世界市場を調査・分析することにより、今後の方向性を明らかに提示しております。市場動向、市場力学、キーインクルージョン、価値分析、薬物クラス別(三環系抗うつ薬、抗痙攣薬、SNRI、カプサイシンクリーム、局所麻酔、オピオイド、ステロイド、その他)分析、疾患別(糖尿病性神経障害、三叉神経痛、帯状疱疹後神経痛、化学療法誘発性末梢神経障害、その他)分析、流通チャンネル別(小売薬局、病院薬局、オンライン薬局)分析、地域別分析、競合分析などを整理しております。

・エグゼクティブサマリー
・市場動向
・市場力学
・キーインクルージョン
・価値分析
・神経障害性疼痛管理の世界市場:薬物クラス別(三環系抗うつ薬、抗痙攣薬、SNRI、カプサイシンクリーム、局所麻酔、オピオイド、ステロイド、その他)
・神経障害性疼痛管理の世界市場:疾患別(糖尿病性神経障害、三叉神経痛、帯状疱疹後神経痛、化学療法誘発性末梢神経障害、その他)
・神経障害性疼痛管理の世界市場:流通チャンネル別(小売薬局、病院薬局、オンライン薬局)
・神経障害性疼痛管理の世界市場:地域別
・競合分析

Neuropathic Pain Management Market – Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global market for neuropathic pain management. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the neuropathic pain management market structure. The market study presents exclusive information about how the neuropathic pain management market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the neuropathic pain management market during the forecast period.

The study is relevant for stakeholders in the neuropathic pain management market, including neuropathic pain management therapy manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the neuropathic pain management market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the neuropathic pain management market. Furthermore, small businesses and new entrants in the neuropathic pain management market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

Key Questions Answered in PMR’s Neuropathic Pain Management Market Report

Which regions will continue to remain the most profitable regional markets for neuropathic pain management market players?
Which factors will induce a change in the demand for neuropathic pain management therapy during the assessment period?
How will changing trends impact the neuropathic pain management market?
How can market players capture the low-hanging opportunities in the neuropathic pain management market in developed regions?
Which companies are leading the neuropathic pain management market?
What are the winning strategies of stakeholders in the neuropathic pain management market to upscale their position in this landscape?
Neuropathic Pain Management Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the neuropathic pain management market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to analysts during the production of the neuropathic pain management market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the neuropathic pain management market, and makes PMR’s projection on the growth prospects of the neuropathic pain management market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Dynamics

3.1. Macro-Economic Factors

3.2. Drivers

3.2.1. Supply Side Drivers

3.2.2. Demand Side Drivers

3.3. Restraints

3.4. Opportunities

3.5. Trends

4. Key Inclusions

4.1. Clinical Trials

5. Global Neuropathic Pain Management Market Value Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 – 2029

6.3.1. Tricyclic Anti-Depressants

6.3.2. Anticonvulsants

6.3.3. SNRI’s

6.3.4. Capsaicin Cream

6.3.5. Local Anaesthesia

6.3.6. Opioids

6.3.7. Steroids

6.3.8. Others

6.4. Market Attractiveness Analysis By Drug Class

7. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Indication

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 – 2029

7.3.1. Diabetic Neuropathy

7.3.2. Trigeminal Neuralgia

7.3.3. Post-Herpetic Neuralgia

7.3.4. Chemotherapy-Induced Peripheral Neuropathy

7.3.5. Others

7.4. Market Attractiveness Analysis By Indication

8. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

8.3.1. Retail Pharmacies

8.3.2. Hospital Pharmacies

8.3.3. Online Pharmacies

8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. Asia Pacific

9.3.5. Middle East and Africa

9.4. Market Attractiveness Analysis By Region

10. North America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Drug Class

10.3.3. By Indication

10.3.4. By Distribution Channel

10.4. Market Attractiveness Analysis

10.5. Key Impact Analysis

11. Latin America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

11.3.1. By Country

11.3.1.1. Brazil

11.3.1.2. Mexico

11.3.1.3. Argentina

11.3.1.4. Rest of Latin America

11.3.2. By Drug Class

11.3.3. By Indication

11.3.4. By Distribution Channel

11.4. Market Attractiveness Analysis

11.5. Key Impact Analysis

12. Europe Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

12.3.1. By Country

12.3.1.1. U.K.

12.3.1.2. Germany

12.3.1.3. France

12.3.1.4. Italy

12.3.1.5. Spain

12.3.1.6. Russia

12.3.1.7. Rest of Europe

12.3.2. By Drug Class

12.3.3. By Indication

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.5. Key Impact Analysis

13. Asia Pacific Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

13.3.1. By Country

13.3.1.1. China

13.3.1.2. India

13.3.1.3. Australia and NZ

13.3.1.4. ASEAN

13.3.1.5. Rest of Asia Pacific

13.3.2. By Drug Class

13.3.3. By Indication

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.5. Key Impact Analysis

14. Middle East and Africa Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

14.3.1. By Country

14.3.1.1. GCC Countries

14.3.1.2. South Africa

14.3.1.3. Rest of MEA

14.3.2. By Drug Class

14.3.3. By Indication

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Key Impact Analysis

15. Competition Analysis

15.1. Competition Dashboard

15.2. Competition Deep Dive

15.2.1. Pfizer Inc.

15.2.1.1. Company Overview

15.2.1.2. Segment Overview

15.2.1.3. ProductOfferings

15.2.1.4. Financial Analysis

15.2.1.5. Key Developments

15.2.1.6. Strategy Overview

15.2.2. Johnson & Johnson Services, Inc.

15.2.2.1. Company Overview

15.2.2.2. Segment Overview

15.2.2.3. ProductOfferings

15.2.2.4. Financial Analysis

15.2.2.5. Key Developments

15.2.2.6. Strategy Overview

15.2.3. Bristol-Myers Squibb Company

15.2.3.1. Company Overview

15.2.3.2. Segment Overview

15.2.3.3. ProductOfferings

15.2.3.4. Financial Analysis

15.2.3.5. Key Developments

15.2.3.6. Strategy Overview

15.2.4. Sanofi S.A

15.2.4.1. Company Overview

15.2.4.2. Segment Overview

15.2.4.3. ProductOfferings

15.2.4.4. Financial Analysis

15.2.4.5. Key Developments

15.2.4.6. Strategy Overview

15.2.5. GlaxoSmithKline plc

15.2.5.1. Company Overview

15.2.5.2. Segment Overview

15.2.5.3. ProductOfferings

15.2.5.4. Financial Analysis

15.2.5.5. Key Developments

15.2.5.6. Strategy Overview

15.2.6. Eli Lilly and Company

15.2.6.1. Company Overview

15.2.6.2. Segment Overview

15.2.6.3. ProductOfferings

15.2.6.4. Financial Analysis

15.2.6.5. Key Developments

15.2.6.6. Strategy Overview

15.2.7. Teva Pharmaceutical Industries Ltd

15.2.7.1. Company Overview

15.2.7.2. Segment Overview

15.2.7.3. ProductOfferings

15.2.7.4. Financial Analysis

15.2.7.5. Key Developments

15.2.7.6. Strategy Overview

15.2.8. Baxter International Inc

15.2.8.1. Company Overview

15.2.8.2. Segment Overview

15.2.8.3. ProductOfferings

15.2.8.4. Financial Analysis

15.2.8.5. Key Developments

15.2.8.6. Strategy Overview

16. Assumptions and Acronyms Used

17. Research Methodology

List of Tables

Table 01: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 02: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 03: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 04: Global Neuropathic Pain Management Size (US$ Mn) 2014-2018 and Forecast 2019-2029 By Region,

Table 05: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 06: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 07: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 08: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 09: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 10: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 11: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 12: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 13: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 14: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 15: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 16: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 17: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 18: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 19: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 20: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

Table 21: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 22: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class

Table 23: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication

Table 24: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel